Market News

208 posts
HEXO - CEO, Scott Cooper.

" HEXO (TSX:HEXO) appoints Scott Cooper as President and CEO

HEXO (HEXO) has announced that Scott Cooper will replace Sebastien St-Louis as its new President and CEO, effective immediately.
Purpose Investments - COO, Vlad Tasevski.

" Purpose Investments Inc. files for the world’s first actively managed crypto ETFs

Purpose Investments has filed a preliminary prospectus for its Crypto Opportunities, Bitcoin Yield and Ether Yield ETFs.
Mountain Boy Minerals - CEO, Lawrence Roulston (right).

" Mountain Boy Minerals (TSXV:MTB) samples high-grade silver in B.C.

Mountain Boy Minerals (MTB) has announced further high-grade silver results on its Theia Project in B.C.

" Equity Metals (TSXV:EQTY) announces private placement

Equity Metals (EQTY) has announced a non-brokered private placement for gross proceeds of up to $6,000,000.
HEXO Corp - Departing CEO, Sebastien St. Louis.

" HEXO’s (TSX:HEXO) St-Louis out as CEO

HEXO (HEXO) has announced executive changes as it completes a strategic reorganization.

" Minaurum Gold (TSXV:MGG) appoints new CFO

Minaurum Gold (MGG) has appointed Jasmine Lau as its new Chief Financial Officer.
BIGG Digital Assets - CEO, Mark Binns.

" BIGG Digital Assets (CSE:BIGG) appoints Mark Binns as acting CEO of Netcoins

BIGG Digital Assets (BIGG) has announced that its CEO, Mark Binns, will assume the role of acting CEO of Netcoins.

" Solar Alliance Energy (TSXV:SOLR) secures one of its largest projects to date

Solar Alliance (SOLR) has signed a contract for a 526 kilowatt solar project in Tennessee.

" Defence Therapeutics (CSE:DTC) Accum variants increases potency of T-Deruxtecan antibody-drug conjugate

Defence Therapeutics’ (DTC) is pleased to announce strong in vitro results of its AccumTM variants on the recent Enhertu®ADC owned by AstraZeneca and

" Blackrock Silver (TSXV:BRC) continues to deliver exceptional results at Tonopah West

Blackrock Silver (BRC) has drilled 5,080 g/t AgEq and cut multiple 1 kg/t intercepts at Tonopah West in Nevada.

" Cruz Battery Metals (CSE:CRUZ) samples high-grade lithium in Nevada

Cruz Battery Metals (CRUZ) has sampled up to 1,610 ppm Li from its Solar Lithium Project in Nevada.

" Equity Metals (TSXV:EQTY) reports bonanza-grade silver from B.C.

Equity Metals (EQTY) has intercepted bonanza-grade silver from offset drilling on its Silver Queen Project in B.C.

" Defence Therapeutics (CSE:DTC) prepares for phase I trial of AccuVAC-D002

Defence Therapeutics (DTC) is preparing to initiate a phase I trial against melanoma using its DC cancer vaccine candidate AccuVAC-D002.
Osisko Mining - CEO, John Burzynski.

" Osisko (TSX:OSK) continues to find high-grade gold in Québec

Osisko Mining (OSK) has returned up to 3,979 g/t Au over 2.3 m from its Windfall Project in Québec.
Nano One Materials - CEO, Dan Blondal

" Nano One (TSX:NANO) and Euro Manganese (TSXV:EMN) sign joint development agreement

Nano One (NANO) is working with Euro Manganese (EMN) to develop manganese products for lithium-ion battery cathode materials.

" IAMGOLD (TSX:IMG) appoints Ann K. Masse to board of directors

IAMGOLD Corporation (IMG) has added Dr. Ann K. Masse as its newest director as it continues to strengthen its leadership team.
Transition Metals - CEO, Scott McLean.

" Transition Metals (TSXV:XTM) reports bonanza-grade gold from Gowganda

Transition Metals (XTM) has sampled bonanza-grade gold on its Gowganda Property in Ontario.
Maple Gold Mines - VP of Exploration, Fred Speidel (left).

" Maple Gold (TSXV:MGM) intersects bonanza-grade gold in Quebec

Maple Gold (MGM) has intersected bonanza-grade gold from the Porphyry Zone at its Douay Project in Quebec.

" CurrencyWorks’ (CSE:CWRK) NFTs for ZERO CONTACT sell for over $90,000

CurrencyWorks (CWRK) is pleased to announce the successful sale of the ZERO CONTACT Platinum Edition and Elite Edition NFTs.

" Defence Therapeutics (CSE:DTC) is preparing to initiate a Phase I trial for one of its leading AccuTOX candidates against breast cancer

Defence Therapeutics (DTC) will be completing all requirements needed to initiate a Phase I trial for one of its leading AccuTOX candidate against